Tech Company Financing Transactions
Vestagen Protective Technologies Funding Round
On 4/13/2017, Vestagen Protective Technologies received $10 million in funding from Advent Life Sciences, HealthQuest Capital and Northwell Ventures.
Transaction Overview
Company Name
Announced On
4/13/2017
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the financing will be used for general corporate purposes and to support increased commercialization activities for Vestagen's innovative VESTEX® Active Barrier fabric scrubs, lab coats and patient garments.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1301 W. Colonial Dr.
Orlando, FL 32804
USA
Orlando, FL 32804
USA
Phone
Website
Email Address
Overview
Vestagen develops and markets advanced performance textile products and technologies. Vestagen has developed VESTEX®, which represents a new class of technology-based, active barrier protective fabrics combining antimicrobial, liquid repellent and breathability properties.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Bold
Chief Technical Officer
Dawn Clarke
Founder
Uncas Favret III
VP - Regulatory Affairs
Scott Pease
Browse more venture capital transactions:
Prev: 4/13/2017: ESO Solutions venture capital transaction
Next: 4/13/2017: Zyme Solutions venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs